Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
254.50    9.50 (3.88%)
Bid:
251.00
Ask:
254.00
Spread: 3.00 (1.195%)
Market Cap: £148.47m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

AGM Statement

11 Dec 2015 07:00

RNS Number : 7616I
MJ Gleeson PLC
11 December 2015
 

MJ Gleeson PLC

(GLE.L)

 

AGM Statement

 

At the Annual General Meeting of M J Gleeson plc (GLE.L), the urban regeneration and strategic land specialist, convened for 11:30 am today in London, the Chairman, Dermot Gleeson, will state:

"Gleeson Homes has performed strongly in the five months to November 2015, during which it has completed 314 sales (compared with 259 sales in the equivalent period last year). The Government's Help to Buy scheme remained popular during the period, with 53% of customers taking advantage of it. Our own bespoke purchaser assistance packages also continued to be attractive.

"The division currently has 44 active sites, compared with 39 at this time last year. A significant number of sites are due to open and management expects the number of active sites to be approaching 50 by June 2016.

"Gleeson Homes currently has a land pipeline of 7,717 plots, of which 4,003 are owned and 3,714 are conditionally purchased, along with a further 961 plots actively being considered.

"The outlook for the division continues to be very encouraging, with strong customer demand in all regions, supported by improved mortgage availability. We are encouraged by the Halifax Building Society's announcement that it will increase its maximum financial exposure to housebuilders' individual development sites from 30% to 50% of total value and we welcome the announcement of further measures to encourage house building in the Autumn Statement.

"Against this very positive background, the Board expects Gleeson Homes to record an increase in completions for the year to 30 June 2016 of not less 15% compared with the prior year total of 751 units.

"In the first five months of the current financial year, Gleeson Strategic Land has performed significantly ahead of the corresponding period last year, selling two sites with planning permission for a combined total of 405 residential units and a site with consent for commercial use on 112.7 thousand square metres.

"The division's land pipeline currently consists of 68 sites, totalling 3,905 gross acres, which have the potential to deliver approximately 21,250 units. The portfolio includes eight sites with either planning permission or a resolution to grant planning permission. Six of these, which will deliver 632 units, are being progressed for sale in the current financial year.

"There are also 20 sites where the division is currently awaiting either the determination of a planning application or the outcome of a planning appeal.

"The Board expects the results, for the Group as a whole, for the first six months to December 2015 to show a strong increase on the first half of the prior financial half year. Based on the current level of trading in Gleeson Homes and the potential for further sales by Gleeson Strategic Land in the second half of the financial year, the Board now believes that results for the full year to 30 June 2016 will exceed expectations."

 

11 December 2015

 

Enquiries:

MJ Gleeson plc

 Tel: +44 1142 612 900

Jolyon Harrison

Chief Executive Officer

Stefan Allanson

Chief Financial Officer

 

Instinctif Partners

Tel: +44 20 7457 2020

Mark Garraway

Helen Tarbet

James Gray

N+1 Singer

Shaun Dobson

Tel: +44 20 7496 3000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMFMMMZVMLGKZG
Date   Source Headline
30th Nov 20237:00 amRNSTotal Voting Rights
27th Nov 20234:29 pmRNSDirector/PDMR Shareholding
16th Nov 20231:33 pmRNSResult of AGM
16th Nov 20237:00 amRNSAGM Trading Update
8th Nov 20233:29 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
24th Oct 20234:17 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:56 pmRNSExercise of Options & Director/ PDMR Dealing
17th Oct 20237:00 amRNSNotice of AGM
6th Oct 20232:37 pmRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSTotal Voting Rights
27th Sep 20234:17 pmRNSExercise of Options & PDMR Dealing
26th Sep 20234:38 pmRNSDirector/PDMR Shareholding
15th Sep 20233:54 pmRNSDirector/PDMR Shareholding
15th Sep 202310:35 amRNSDirector/PDMR Shareholding
14th Sep 20234:41 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSAudited results for the year ended 30 June 2023
7th Sep 202312:20 pmRNSDirector/PDMR Shareholding
31st Aug 20237:00 amRNSTotal Voting Rights
8th Aug 20234:55 pmRNSDirector/PDMR Shareholding
31st Jul 20237:00 amRNSTotal Voting Rights
7th Jul 20233:48 pmRNSDirector/PDMR Shareholding
7th Jul 20237:00 amRNSTrading Update and Capital Markets Day
30th Jun 20237:00 amRNSSale of portfolio of homes to Carlyle
30th Jun 20237:00 amRNSTotal Voting Rights
8th Jun 20232:23 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
15th May 20233:30 pmRNSHolding(s) in Company
10th May 20231:56 pmRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
14th Apr 202310:01 amRNSDirector/PDMR Shareholding
6th Apr 202311:13 amRNSDirector/PDMR Shareholding
5th Apr 20234:37 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
24th Mar 20237:00 amRNSRe Directorate
21st Mar 20237:00 amRNSNotice of Capital Markets Day and Trading Update
13th Mar 20233:58 pmRNSSigning of the Self-Remediation Terms
8th Mar 20235:13 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSTotal Voting Rights
27th Feb 202312:05 pmRNSPerformance Share Plan award to Directors & PDMRs
16th Feb 20237:00 amRNSResults for the half-year ended 31 December 2022
8th Feb 20235:18 pmRNSCommittee appointments
8th Feb 20231:45 pmRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
13th Jan 20237:00 amRNSTrading Update & Notice of Results
6th Jan 20234:42 pmRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSRe Directorate
30th Dec 20227:00 amRNSTotal Voting Rights
15th Dec 202211:06 amRNSDirectorate External Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.